跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALOCARE 2,275 MG/ML SOLUCION PARA PULVERIZACION CUTANEA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ALOCARE 2,275 MG/ML SOLUCION PARA PULVERIZACION CUTANEA
Approved
STANDARD
ALOCARE 2,275 MG/ML SOLUCION PARA PULVERIZACION CUTANEA
Industrial Farmaceutica Cantabria S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 12, 2022
Approval ID
21da1a20041166e4
Company
Industrial Farmaceutica Cantabria S.A.
Type
Standard
Approval Details
Approval Id
21da1a20041166e4
Drug Cima Aemps Name
ALOCARE 2,275 MG/ML SOLUCION PARA PULVERIZACION CUTANEA
Register Number
86827
Holder Company Name
Industrial Farmaceutica Cantabria S.A.
Marketing Company Name
Industrial Farmaceutica Cantabria S.A.
Authorization Date
2022-04-12
Dosage Form
SOLUCIÓN PARA PULVERIZACIÓN CUTÁNEA
Dose
2,275 mg/ml
Route Of Administration
USO CUTÁNEO
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Industrial Farmaceutica Cantabria S.A.
Active Ingredients
FINASTERIDA
2,275 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 12, 2022
Approval ID
21da1a20041166e4
Type
Standard
Back to CIMA-AEMPS Approvals
